Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Survival benefits of Canvaxin in metastatic melanoma

July 29, 2004

Combination regimens in the treatment of CTCL

July 29, 2004

Antisoma gains rights to BC1-IL12

July 28, 2004

New phase II biomarker trial for SGN-15

July 27, 2004

First phase III study of GVAX prostate cancer vaccine commences enrollment

July 21, 2004

Therapeutic benefits of recombinant PSA vaccines in advanced prostate cancer

July 13, 2004

European orphan medicinal product status for Mepat in osteosarcoma

July 12, 2004

Dosing commences in phase III trial of TransMID for glioblastoma multiforme

July 8, 2004

AltaRex signs distribution agreement with Dompe

July 8, 2004

First description of lipoptosis using IgM antibody SAM-6

July 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...